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ABSTRACT 
 4
Exercise leads to increased metabolic request and this represents a challenge 
for the cardiopulmonary system, which must guarantee O2 and CO2 transfer and 
exchange. Ventilation (VE) and circulation are responsible for gas transfer, 
whereas gas exchange is due to both pulmonary and cellular diffusion. 
 
At rest, muscle work is limited to that of the heart and the respiratory and bowel 
muscles. During exercise limb muscles work is added and leads to an increase 
in adenosine triphosphate (ATP) request and oxygen consumption (V’O2) and 
carbon dioxide production (V’CO2). As the exercise intensifies, the aerobic 
metabolism can not supply all the ATP quantity requested. Consequently, the 
anaerobic metabolism takes over, leading to increased lactic acid output.  
 
In healthy sedentary subjects, who perform a maximal exercise, VE values range 
from 5-10 L/min at rest to 80-100 L/min at peak of exercise. Cardiac output (CO) 
increases linearly as external work increases, from 4-6 L/min at rest to 20 L/min 
at peak of exercise. In healthy sedentary subjects the factors which lead to 
exercise limitation are reaching the maximal CO, and consequently the maximal 
capacity of gas transfer to tissues, and depletion of glycogen stocks.  
 
In heart and respiratory diseases, the cardiopulmonary exercise test (CPET) 
provides an overall assessment of functional capacity and allows to evaluate 
disease severity, prognosis and therapeutic interventions. Both in respiratory 
and cardiac patients exercise intolerance reflects integrated abnormalities of the 
ventilatory, cardiovascular, peripheral muscle, and neurosecretory systems. The 
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CPET is able to identify which dysfunctional component impacts exercise 
capacity to the greatest extent.  
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ABBREVIATIONS 
A-aDO2 = alveolar-capillary oxygen gradient  
AT = anaerobic threshold 
ATP = adenosine triphosphate 
CaO2 = arterial oxygen content 
CO = cardiac output 
CPET = cardiopulmonry exercise test 
CvO2 = venous oxygen content 
EELV = end-expiratory lung volume 
EILV = end-inspiratory lung volume 
HF = heart failure 
HR = heart rate 
PO2 = oxygen partial pressure 
RR = respiratory rate 
SV = stroke volume 
TE = expiratory time 
TI = inspiratory time 
VC = vital capacity  
V’CO2 = carbon dioxide production 
VD = dead space 
VE = ventilation (L/min) 
V’O2 = oxygen consumption 
VT = tidal volume 
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Exercise physiology  
Exercise leads to increased metabolic request and this represents a challenge 
for the cardiopulmonary system, which must guarantee O2 and CO2 transfer and 
exchange. At the same time, in the face of increased metabolic demands the 
objective of the cardiorespiratory system is to minimize the increase in work 
performed by the heart and respiratory muscles.  
 
Gas transport and exchange at rest 
Ventilation (VE) and circulation are responsible for gas transfer, whereas gas 
exchange is due to both pulmonary and cellular diffusion [1,2] (fig.1). VE can be 
considered as the product of respiratory rate (RR) and tidal volume (VT). VE 
supplies continuously O2 to the lungs and removes CO2 to the atmosphere. A 
part of the lungs, called dead space (VD), does not participate to gas exchange. 
Dead space comprises conduction airways (anatomic dead space) and alveoli 
with low or no perfusion (alveolar dead space). Pulmonary diffusion is 
responsible for O2 and CO2 exchange between alveoli and pulmonary blood 
vessels. The exchange occurs because of passive diffusion, which is 
determined by the barometric gradients of O2 and CO2 (60-65 mmHg for O2 and 
5 mmHg for CO2) [1], diffusivity (CO2 is twenty-fold more diffusible than O2), 
surface (70 m2) and thickness (0,4-2 µ) of the alveolar-capillary interface. The 
transit time of red cells through pulmonary vessels is 0.75 seconds and O2 
diffusion occurs in 0,25 seconds. At the end of the exchange, the barometric 
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gradients between alveoli and pulmonary blood vessels are 5-10 mm Hg for O2 
and 0 for CO2 [3]. 
 
The cardiovascular system transfers O2 from lungs to tissues and viceversa for 
CO2. The cardiac output (CO), which can be considered as the product of stroke 
volume (SV) and heart rate (HR), pushes the blood from the heart to the 
circulatory system. The volume of O2 transferred each minute to the tissues 
equals to the product of CO and arterial O2 content (CaO2).  A part of the 
transferred oxygen is released to tissues, whereas another one returns to the 
heart. The quantity of O2 which returns to the heart is equal to the product of CO 
and venous O2 content (CvO2). The difference between these two components 
[CO(CaO2)-(CvO2)]  represents O2 consumption (V’O2) by tissues. Cellular 
diffusion allows gas exchange between blood vessels and cells, where oxygen 
consumption (V’O2) and carbon dioxide production (V’CO2) are 250 mL/min and 
200 mL/min respectively, at rest. 
 
Physiologic response to exercise 
At rest, muscle work is limited to that of the heart and the respiratory and bowel 
muscles. During exercise limb muscles work is added and leads to an increase 
in adenosine triphosphate (ATP) request and V’O2 and V’CO2 (fig. 2). As the 
exercise intensifies, the aerobic metabolism can not supply all the ATP quantity 
requested. Consequently, the anaerobic metabolism takes over, leading to 
increased lactic acid output. The anaerobic metabolism is less efficient than the 
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aerobic one, since the glycolytic oxidative process produces 36 ATP molecules, 
in contrast to the anaerobic one, which produces only two. 
 
Normally, during a progressively incremental exercise V’O2 increases nearly 
linearly as external work increases, up to seven to eight-fold the rest value (fig. 
3). V’CO2 varies in line with V’O2, but overtakes V’O2 increase above the point of 
anaerobic threshold (AT) (fig. 3). In normal individuals the AT occurs at about 
50% ± 10 of maximal V’O2. In general, after the AT is reached, subjects may 
complain of dyspnoea and/or leg fatigue. In order to support the augmented 
metabolic demands of exercising muscles, VE and CO increase during exercise. 
 
At the beginning of exercise VE increases before a significant increase in V’O2 
and V’CO2, then increases linearly until the AT [4,5] (fig. 4). Afterward, the rise in 
VE is superior to that of the workload, in order to balance the V’CO2 increase 
due to the anaerobic metabolism (fig. 4). In healthy sedentary subjects, who 
perform a maximal exercise, VE values range from 5-10 L/min at rest to 80-100 
L/min at peak of exercise. The rise in VE with exercise is associated with an 
increase in both depth and frequency of breathing (fig. 4). In health, increases in 
VT are primarily responsible for increases in ventilation during low levels of 
exercise. As exercise progresses, both VT and RR increase until 70 to 80% of 
peak exercise; thereafter RR predominates [1]. Younger adults typically increase 
VT by three- to fivefold whereas in older adults VT tends to increase two- to four-
fold (from 0.5-1.0L at rest, which is 10% of vital capacity, to 2.3-3.0 L, which is 
50% of vital capacity) [6]. In healthy subjects, the increase in VT is due to both a 
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decrease in end-expiratory lung volume (EELV), but predominantly to an 
increase in end-inspiratory lung volume (EILV) through a decrease in the 
inspiratory reserve volume [7]. RR typically increases one- to three-fold in most 
subjects (from 12-16 apm to 40-50 apm). The increase in RR with exercise 
reflects a decrease in both inspiratory (TI) and expiratory (TE) time. Typically, 
however, at the moderate to higher ventilatory demands, a greater fractional 
decrease is noted in TE, so that TI/Ttot increases from 0.4 at rest to 0.5-0.55 at 
maximal exercise. 
 
CO increases with exercise, leading to an improved alveolar perfusion, so that 
the alveolar VD decreases. At peak exercise the transit time of red cells through 
pulmonary vessels is 0.38 seconds, however, in healthy subjects gas exchange 
is still efficient. The alveolar-capillary O2 gradient (A-aDO2) may be amplified 
during intense exercise up to 20 mmHg [8,9]. Indeed, alveolar O2 partial 
pressure (PO2) increases with VE, especially above the AT [10]. However, the 
arterial PO2 does not vary, thus the A-aDO2 increases  [11]. Arterial PO2 does 
not increase because of the low venous PO2, due to high O2 extraction from 
tissues. 
 
CO increases linearly as external work increases, from 4-6 L/min at rest to 20 
L/min in healthy sedentary subjects (fig. 5). Increases in CO are initially 
accomplished by increases in SV and HR, and then at moderate-to-high 
intensity exercise almost exclusively by increases in HR (fig. 5). The increase in 
CO is largely driven by vagal withdrawal and by increases in circulating or 
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neurally produced cathecolamines. In healthy subjects, the SV is 50-80 ml at 
rest and redoubles at peak exercise. HR increases nearly linearly with 
increasing V’O2 up to 2.5-4 times as much as the rest value. 
 
The exercise ends when intolerable perception of either leg fatigue or dyspnoea 
occurs. In healthy sedentary subjects the factors which lead to exercise 
limitation are reaching the maximal CO, and consequently the maximal capacity 
of gas transfer to tissues, and depletion of glycogen stocks [12,13]. 
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Exercise limitations in heart failure 
Heart failure (HF) is a multiorgan syndrome. The cardiopulmonary exercise test 
(CPET) provides an overall assessment of functional capacity and allows to 
evaluate disease severity, prognosis and therapeutic interventions. The CPET is 
also able to identify which dysfunctional component impacts exercise capacity in 
HF to the greatest extent. Several organs can be the limiting factor of exercise in 
HF [14]. As a consequence, there is not a single parameter at rest which can 
predict exercise capacity. 
 
The heart is the organ from which HF starts. However, when HF is overt, it may 
not be the leading cause of exercise limitation. In the presence of exercise 
limitation a prevalence of cardiac dysfunction is suggested by a reduced V’O2 at 
anaerobic threshold, a decreased HR difference between rest and peak 
exercise, a reduction in O2 maximum pulse and a reduced slope of 
V’O2/workload relationship [15,16]. Because of a reduction in oxygen delivery to 
the muscles, energy is provided by anaerobic pathways even at low workload, 
which determines an early AT. The difference between rest and peak exercise 
HR is reduced because resting HR is higher than in healthy subjects, unless 
patients are treated with β-blockers, and because peak exercise HR is low due 
to chronotropic incompetence or treatment. The O2 pulse is clinically utilized as 
an index of SV. Infact, the O2 pulse can be considered as the product of SV and 
arteriovenous O2 difference, thereby being related to SV. A reduced 
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V’O2/workload relationship slope through the exercise is an index of reduced CO 
response to exercise. 
 
Moreover, alteration in peripheral circulation can contribute to limiting exercise 
capacity in HF, since fluid accumulates both inside the vascular wall and in the 
tissues, increasing the distance between capillary and mitochondria. However, 
no specific parameters derived from CPET can be used to suggest a peripheral 
circulatory alteration in HF. 
 
HF patients develop a skeletal and respiratory myopathy, due to inactivity, 
malnutrition and increase of inflammatory status, which not only induces fatigue 
and dyspnoea, but also increases ventilation and peripheral vasoconstriction 
through an increased sympathetic activity [17,18]. Accordingly, elements which 
suggest that the peripheral muscles are the major cause of exercise limitation 
are symptoms such as leg fatigue and a reduced V’O2/workload slope.  
 
In HF patients, respiratory function during exercise can be impaired because of 
mechanical and diffusion alterations [16]. The former is characterized by an 
increase in VE due to reduction in VT and increase in RR [19]. The increase in VE 
is relative to work rate, V’O2 and V’CO2. As a consequence, HF patients may 
present an elevated ratio of ventilation to CO2 production (VE/V’CO2) during 
exercise. The abnormal increase in VE/VC’O2 slope may be due to several 
factors, including the earlier onset of metabolic acidosis and a disproportionately 
high dead space from poor pulmonary perfusion [16,20].The parameters which 
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suggest lung mechanical alterations are increased VE, reduced VT, increased 
VD/VT ratio and increased RR. Also lung diffusion is altered in HF. Indeed, albeit 
the capillary blood volume increase during exercise, this is not enough to 
compensate the specific membrane diffusive capability reduction. This is likely 
due to increase in fibrosis and cellular content at the alveolar-capillary 
membrane. Furthermore, lung diffusion increase during exercise is blunt in HF 
patient. 
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Exercise limitations in respiratory patients 
In respiratory patients exercise intolerance reflects integrated abnormalities of 
the ventilatory, cardiovascular, peripheral muscle, and neurosecretory systems 
[21]. Ventilatory limitation is often the predominant contributor to exercise 
intolerance, while at the same time cardiac and other physiological functions are 
operating below maximal capacity. One of the distinguishing features of 
respiratory patients is a reduced ventilatory reserve, signaling a significant 
ventilatory contribution to exercise limitation. The breathing strategy adopted by 
respiratory patients during exercise includes a higher RR and a lower VT 
compared with healthy subjects. 
 
In COPD patients the crucial abnormality is expiratory flow limitation (EFL) due 
to combined reduced lung recoil as well as airway narrowing. When EFL 
reaches a critical level, lung emptying becomes incomplete, EELV increases 
and patients experience air trapping [22,23,24]. This phenomenon is known as 
exercise dynamic hyperinflation. When breathing at a high dynamic EELV the 
pressure generating capacity of the inspiratory muscles and, thus, the ability to 
generate inspiratory flow, may be compromised [22]. An important mechanical 
consequence of dynamic hyperinflation is a limitation on VT expansion during 
exercise. Moreover, in flow-limited patients, inspiration begins before tidal lung 
emptying is complete and the inspiratory muscles must first counterbalance the 
combined recoil at the lung and chest wall before inspiratory flow is initiated. 
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This phenomenon is associated with positive intrapulmonary pressures at the 
end of expiration and may have important implications for dyspnoea perception.  
 
Peripheral muscle dysfunction is another  potential cause of exercise intolerance 
[18,25,26,27]. Abnormalities of peripheral muscle structure and function, such as 
loss of muscle mass and mitochondrial compromised oxidative phosphorylation 
have been described [28]. Muscle biopsies have shown reduced capillarization, 
reduction in type 1 high oxidative, fatigue-resistant fibers and increase in type 2 
fibers, which are characterized by low mechanical efficiency and increased 
fatigability [29]. 
 
In respiratory patients arterial hypoxemia during exercise commonly occurs, as a 
result of the effect of a fall in mixed venous O2 tension on low ventilation-
perfusion lung units, and shunting [30,31]. Both the ability to increase lung 
perfusion and to distribute inspired ventilation throughout the lungs during 
exercise is compromised. Resting physiological dead space is often increased, 
reflecting ventilation-perfusion inequalities, and fail to decline further during 
exercise.  Inefficient ventilation due primarily to increased VD/VT and also 
hyperventilation due to hypoxemia and mechanoreceptor stimulation are usually 
observed throughout exercise. Hypoxemia not only contributes to the 
exaggerated ventilatory response, but may also contribute to reduced O2 
delivery primarily through a reduced O2 content and also via hypoxic 
vasoconstriction. 
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Cardiovascular abnormalities are common and reflect pulmonary vascular and 
right ventricular dysfunction [32,33]. Pulmonary artery pressures and right 
ventricular afterload are generally higher than in healthy subjects, because of 
the increased vascular resistance. The left ventricular ejection fraction is 
generally preserved, whereas left ventricular diastolic function may be impaired 
due to ventricular interdependence; infact, increased tension or displacement of 
the right ventricle may impede left diastolic filling. Left ventricular afterload is 
also increased during exercise, because the left-ventricular transmural pressure 
gradient is increased as a result of progressively negative intrathoracic pressure 
generation. Consequently, in respiratory patients low peak HR responses are 
usually observed, thus HR reserve may be increased or normal and O2 pulse 
reduced. 
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Figure 1. Relationship among physiologic mechanisms which support 
muscles work at rest. 
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Figure 2. Physiologic response to exercise. 
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Figure 3. Metabolic parameters during a progressively incremental 
maximal exercise. 
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Figure 4. Ventilatory parameters during a progressively incremental 
maximal exercise. 
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Figure 5. Cardiovascular parameters during a progressively incremental 
maximal exercise. 
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